Arimed Inc.
Records under this name other than patents Arimed Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Showing 1 to 7 of 7 · Back to Arimed Inc.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,952,164 | R-7-(3-Aminomethyl-4-Methoxyimino-3-Methyl-PYRROLIDIN-1-YL)-1-Cyclopropyl-6-Fluoro-4-OXO-1,4-Dihydro-[1,8]NAPHTHYRIDINE-3-Carboxylic Acid and L-Aspartic Acid Salt, Process for the Preparation Thereof and Pharmaceutical Composition Comprising the Same for Antimicrob Formerly held In force · Medium confidence | In force | Medium confidence | |
| US 9,150,576 | R-7-(3-aminomethyl-4-methoxyimino-3-methyl-pyrrolidin-1-yl)-1-cyclopropyl-6-fluoro-4-oxo-1 acid and L-aspartic acid salt, process for the preparation thereof and pharmaceutical composition comprising the same for antimicrobial Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 8,664,240 | R-7-(3-aminomethyl-4-methoxyimino-3-methyl-pyrrolidin-1-yl)-1-cyclopropyl-6-fluoro-4-oxo-1,4-dihydro-[1,8]naphthyridine-3-carboxylic acid and L-aspartic acid salt, process for the preparation thereof and pharmaceutical composition comprising the same for antimicrobial Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 9,446,061 | Composition containing antibiotics and lysophosphatidylcholine for boosting immunity or treatment of bacterial infections Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 7,410,955 | Therapeutic use of agonist ligands specific to G2A receptor Formerly held Term ended Term ended Mar 25, 2023 · From the USPTO record | Term ended | Term ended Mar 25, 2023 | From the USPTO record |
| US 6,753,430 | Optically active quinoline carboxylic acid derivatives with 7-pyrrolidine substituents causing optical activity and a process for the preparation thereof Formerly held Term ended Term ended Nov 20, 2021 · From the USPTO record | Term ended | Term ended Nov 20, 2021 | From the USPTO record |
| US 6,649,763 | Optically active quinoline carboxylic acid derivatives with 7-pyrrolidine substituents causing optical activity and a process for the preparation thereof Formerly held Term ended Term ended Nov 16, 2021 · From the USPTO record | Term ended | Term ended Nov 16, 2021 | From the USPTO record |